Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 28 June 1991:
Vol. 252. no. 5014, pp. 1798 - 1804
DOI: 10.1126/science.1829547

Articles

Science, Vol 252, Issue 5014, 1798-1804
Copyright © 1991 by American Association for the Advancement of Science


articles

Benefits and costs of HIV testing

DE Bloom and S Glied

Department of Economics, Columbia University, New York, NY 10027.

The benefits and costs of human immunodeficiency virus (HIV) testing in employment settings are examined from two points of view: that of private employers whose profitability may be affected by their testing policies and that of public policy-makers who may affect social welfare through their design of regulations related to HIV testing. The results reveal that HIV testing is clearly not cost-beneficial for most firms, although the benefits of HIV testing may outweigh the costs for some large firms that offer generous fringe-benefit packages and that recruit workers from populations in which the prevalence of HIV infection is high. The analysis also indicates that the testing decisions of unregulated employers are not likely to yield socially optimal economic outcomes and that existing state and federal legislation related to HIV testing in employment settings has been motivated primarily by concerns over social equity.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Cost-Effectiveness of HIV Testing: Accounting for Differential Participation Rates.
A. D. Paltiel and E. H. Kaplan (1997)
Med Decis Making 17, 490-495
   Abstract »    PDF »
Economic Impact of Treatment of HIV-Positive Pregnant Women and Their Newborns With Zidovudine: Implications for HIV Screening.
J. A. Mauskopf, J. E. Paul, D. S. Wichman, A. D. White, and H. H. Tilson (1996)
JAMA 276, 132-138
   Abstract »    PDF »
The Cost-effectiveness of Voluntary Counseling and Testing of Hospital Inpatients for HIV Infection.
P. Lurie, A. L. Avins, K. A. Phillips, J. G. Kahn, R. A. Lowe, and D. Ciccarone (1994)
JAMA 272, 1832-1838
   Abstract »    PDF »
Human Immunodeficiency Virus Counseling, Testing, Referral, and Partner Notification Services: A Cost-Benefit Analysis.
D. R. Holtgrave, R. O. Valdiserri, A. R. Gerber, and A. R. Hinman (1993)
Arch Intern Med 153, 1225-1230
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)